Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.
Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Association between parasite infection and immune responses in multiple sclerosis.
Nrf2 in health and disease: current and future clinical implications.
Bioinformatics challenges for genome-wide association studies.
The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).
MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
Severe dystonia as the first manifestation of neuromyelitis optica.
The effect of an AFO-shaped elastic band on drop-foot gait in patients with central neurological lesions.
Long-term Analyses of Innervation and Neuromuscular Integrity in the Trembler-J Mouse Model of Charcot-Marie-Tooth Disease.
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
Neuropathic pruritus (itch) in neuromyelitis optica.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis.
Reported outcomes after the endovascular treatment of chronic cerebrospinal venous insufficiency.

Pages